
Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol
Keywords: AHMC; 3-[2-(diethylamino)ethyl]-7-hydroxy-4-methylcoumarin hydrochloride; AMMC; 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin; BHT; butylated hydroxytoluene; CAR; constitutive androstane receptor; CYP or P450; cytochrome P450; DCPIP